Aspirin for patients after TIPS: an old dog with new tricks?

Jitao Wang^{1

2}, Dengxiang Liu², Shubo Chen², Xiaolong Qi³

Affiliations

¹ Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, Gansu, China.
² Xingtai Key Laboratory of Precision Medicine for Liver Cirrhosis and Portal Hypertension, Xingtai People's Hospital of Hebei Medical University, Xingtai, 054001, Hebei, China.
³ Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, Gansu, China. qixiaolong@vip.163.com.

Comment

Jitao Wang et al. Hepatol Int. 2022 Oct.

. 2022 Oct;16(5):1244-1245.

doi: 10.1007/s12072-022-10383-y. Epub 2022 Jun 29.

Jitao Wang^{1

2}, Dengxiang Liu², Shubo Chen², Xiaolong Qi³

¹ Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, Gansu, China.
² Xingtai Key Laboratory of Precision Medicine for Liver Cirrhosis and Portal Hypertension, Xingtai People's Hospital of Hebei Medical University, Xingtai, 054001, Hebei, China.
³ Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, Gansu, China. qixiaolong@vip.163.com.

No abstract available

Comment in

Response to: Aspirin for patients after TIPS. An old dog with new tricks?
Seifert LL, Schindler P, Bettinger D, Trebicka J, Wildgruber M, Heinzow H. Seifert LL, et al. Hepatol Int. 2022 Oct;16(5):1246-1247. doi: 10.1007/s12072-022-10394-9. Epub 2022 Jul 29. Hepatol Int. 2022. PMID: 35904749 Free PMC article. No abstract available.

Aspirin improves transplant-free survival after TIPS implantation in patients with refractory ascites: a retrospective multicentre cohort study.
Seifert LL, Schindler P, Sturm L, Gu W, Seifert QE, Weller JF, Jansen C, Praktiknjo M, Meyer C, Schoster M, Wilms C, Maschmeier M, Schmidt HH, Masthoff M, Köhler M, Schultheiss M, Huber JP, Bettinger D, Trebicka J, Wildgruber M, Heinzow H. Seifert LL, et al. Hepatol Int. 2022 Jun;16(3):658-668. doi: 10.1007/s12072-022-10330-x. Epub 2022 Apr 5. Hepatol Int. 2022. PMID: 35380386 Free PMC article.

1. Seifert LL, Schindler P, Sturm L, et al. Aspirin improves transplant-free survival after TIPS implantation in patients with refractory ascites: a retrospective multicentre cohort study. Hepatol Int. 2022. https://doi.org/10.1007/s12072-022-10330-x - DOI - PubMed
1. Davidson KW, Barry MJ, US Preventive Services Task Force, et al. Aspirin use to prevent cardiovascular disease: US preventive services task force recommendation statement. JAMA. 2022;327:1577–1584 - DOI
1. Huang Y, Lee C, Yang S, et al. Statins reduce the risk of cirrhosis and its decompensation in chronic hepatitis B patients: a nationwide cohort study. Am J Gastroenterol. 2016;111:976–985 - DOI
1. Singh J, Wozniak A, Cotler SJ, et al. Combined use of aspirin and statin is associated with a decreased incidence of hepatocellular carcinoma. J Clin Gastroenterol. 2022;56:369–373 - DOI
1. Angeli P, Bernardi M, Villanueva C, et al. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–460 - DOI